Kathy L. Rowlen PhD

Dr. Kathy Rowlen has more than 20 years of management and research experience in business and academics, with more than 10 years in the field of biotechnology. As a Professor of Chemistry at the University of Colorado in Boulder she graduated 20 Ph.D. scientists and mentored numerous post-doctoral research associates and undergraduate students. During her 17 year tenure, Dr. Rowlen gave well over 100 invited talks, was inventor on several patents and pending patents, and published more than 80 scientific papers. In January of 2008 she transitioned to a full-time position at InDevR as CEO.
,br/> Dr. Rowlen has a well-earned reputation as a resourceful business entrepreneur and has raised more than $11 million in non-diluted company funding. Included in this fundraising is a significant five year cooperative agreement with NIH for InDevR’s ampliPHOX technology and Phase I & II NIH SBIR funding for both the Virus Counter product line and the FluChip. A rarity in business and biotechnology, all of the hardware, software and reagents for all of their products, from conception to launch, were designed and developed at the Boulder facility.

Dr. Rowlen has advanced the business structure of InDevR, creating effective sales, marketing and business development teams. After a 2010 commercial launch of the Virus Counter, InDevR will recognize revenue from the sales of these products in 2011. The company now has a global distribution network to sell the Virus Counter in the US, China, India, Japan, Korea, Belgium, Luxembourg, the Netherlands, and the United Kingdom. Under Dr. Rowlen’s leadership, the company received a 2010 “Colorado Companies to Watch” award.